[go: up one dir, main page]

FR2733750B1 - Derives de l'acide gamma-oxo-alpha-(phenylmethyl)-5,6- dihydro-4h-thieno(3,4-c)pyrrole-5-butanoique, leur preparation et leur application en therapeutique - Google Patents

Derives de l'acide gamma-oxo-alpha-(phenylmethyl)-5,6- dihydro-4h-thieno(3,4-c)pyrrole-5-butanoique, leur preparation et leur application en therapeutique

Info

Publication number
FR2733750B1
FR2733750B1 FR9505260A FR9505260A FR2733750B1 FR 2733750 B1 FR2733750 B1 FR 2733750B1 FR 9505260 A FR9505260 A FR 9505260A FR 9505260 A FR9505260 A FR 9505260A FR 2733750 B1 FR2733750 B1 FR 2733750B1
Authority
FR
France
Prior art keywords
butanoique
thieno
phenylmethyl
pyrrole
dihydro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9505260A
Other languages
English (en)
Other versions
FR2733750A1 (fr
Inventor
Zurita Manuel Bedoya
Martin Juan Antonio Diaz
Sol Moreno Gregorio Del
Escudero Ulpiano Martin
Bargueno Maria Dolores Jimenez
Ferrer Magali Romanach
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9505260A priority Critical patent/FR2733750B1/fr
Application filed by Synthelabo SA filed Critical Synthelabo SA
Priority to KR1019970707802A priority patent/KR19990008276A/ko
Priority to NZ307230A priority patent/NZ307230A/en
Priority to AU56520/96A priority patent/AU699120B2/en
Priority to US08/945,576 priority patent/US5869518A/en
Priority to TR97/01287T priority patent/TR199701287T1/xx
Priority to HU9903886A priority patent/HUP9903886A3/hu
Priority to EE9700288A priority patent/EE9700288A/xx
Priority to BR9608309A priority patent/BR9608309A/pt
Priority to CA002220015A priority patent/CA2220015A1/fr
Priority to SK1478-97A priority patent/SK147897A3/sk
Priority to PCT/FR1996/000555 priority patent/WO1996034870A1/fr
Priority to CZ973466A priority patent/CZ346697A3/cs
Priority to EP96913576A priority patent/EP0823912A1/fr
Priority to PL96323177A priority patent/PL323177A1/xx
Priority to JP8533065A priority patent/JPH11504913A/ja
Priority to AR33637996A priority patent/AR001838A1/es
Priority to ZA963485A priority patent/ZA963485B/xx
Priority to CO96021765A priority patent/CO4750652A1/es
Priority to IL11811996A priority patent/IL118119A0/xx
Publication of FR2733750A1 publication Critical patent/FR2733750A1/fr
Application granted granted Critical
Publication of FR2733750B1 publication Critical patent/FR2733750B1/fr
Priority to MXPA/A/1997/008322A priority patent/MXPA97008322A/xx
Priority to NO975020A priority patent/NO975020L/no
Priority to BG102015A priority patent/BG102015A/xx
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Indole Compounds (AREA)
FR9505260A 1995-05-03 1995-05-03 Derives de l'acide gamma-oxo-alpha-(phenylmethyl)-5,6- dihydro-4h-thieno(3,4-c)pyrrole-5-butanoique, leur preparation et leur application en therapeutique Expired - Fee Related FR2733750B1 (fr)

Priority Applications (23)

Application Number Priority Date Filing Date Title
FR9505260A FR2733750B1 (fr) 1995-05-03 1995-05-03 Derives de l'acide gamma-oxo-alpha-(phenylmethyl)-5,6- dihydro-4h-thieno(3,4-c)pyrrole-5-butanoique, leur preparation et leur application en therapeutique
EP96913576A EP0823912A1 (fr) 1995-05-03 1996-04-12 Derives d'azacycloalcanes, leur preparation et leurs applications en therapeutique
AU56520/96A AU699120B2 (en) 1995-05-03 1996-04-12 Azacycloalcane derivatives, their preparation and their applications in therapy
US08/945,576 US5869518A (en) 1995-05-03 1996-04-12 Azacycloalkane derivatives, their preparation and their application in therapy
TR97/01287T TR199701287T1 (xx) 1995-05-03 1996-04-12 Azasikloalkan t�revleri, haz�rlan��lar� ve terapideki uygulamalar�.
HU9903886A HUP9903886A3 (en) 1995-05-03 1996-04-12 Azacycloalcane derivatives, preparation thereof and their applications in therapy
EE9700288A EE9700288A (et) 1995-05-03 1996-04-12 Asatsükloalkaani derivaadid, nende valmistamine ja kasutamine ravis
NZ307230A NZ307230A (en) 1995-05-03 1996-04-12 Furo[3,4-c]pyrrole, isoindole or thieno[3,4-c]pyrrole derivatives and medicaments
CA002220015A CA2220015A1 (fr) 1995-05-03 1996-04-12 Derives d'azacycloalcanes, leur preparation et leurs applications en therapeutique
SK1478-97A SK147897A3 (en) 1995-05-03 1996-04-12 Azacycloalcane derivatives, preparation thereof and their applications in therapy
PCT/FR1996/000555 WO1996034870A1 (fr) 1995-05-03 1996-04-12 Derives d'azacycloalcanes, leur preparation et leurs applications en therapeutique
JP8533065A JPH11504913A (ja) 1995-05-03 1996-04-12 アザシクロアルカン誘導体、その製造および治療への適用
KR1019970707802A KR19990008276A (ko) 1995-05-03 1996-04-12 아자시클로알칸 유도체, 그것의 제법 및 그것의 치료에의 이용
PL96323177A PL323177A1 (en) 1995-05-03 1996-04-12 Azacycloalcane derivatives, method of obtaining them and their application for therapeutic purposes
CZ973466A CZ346697A3 (cs) 1995-05-03 1996-04-12 Deriváty azacykloalkanů, způsob jejich přípravy a farmaceutické kompozice tyto deriváty obsahující
BR9608309A BR9608309A (pt) 1995-05-03 1996-04-12 Derivados de azacicloalcanos dua preparação e suas aplicações em terapêutica
ZA963485A ZA963485B (en) 1995-05-03 1996-05-02 Azacycloalkane derivatives, their preparation and their application in therapy
CO96021765A CO4750652A1 (es) 1995-05-03 1996-05-02 Derivados de azacicloalcanos, su preparacion y sus aplica- ciones en terapeutica
IL11811996A IL118119A0 (en) 1995-05-03 1996-05-02 Azacycloalkane derivatives their preparation and their application in therapy
AR33637996A AR001838A1 (es) 1995-05-03 1996-05-02 Derivados de azacicloal canos utiles para el tratamiento de la obesidad diabetes e hiperglucemia procedimiento para prepararlos composiciones farmacéuticas que los contienen y aplicación de dichos derivados en la preparación de dichas composiciones
MXPA/A/1997/008322A MXPA97008322A (en) 1995-05-03 1997-10-29 Derivatives of aza cicloalcano, its preparation and its applications in tera
NO975020A NO975020L (no) 1995-05-03 1997-10-31 Azacykloalkanderivater, fremstilling derav og deres anvendelse i terapi
BG102015A BG102015A (en) 1995-05-03 1997-11-03 Azacycloalkane derivatives, their preparation and application in therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9505260A FR2733750B1 (fr) 1995-05-03 1995-05-03 Derives de l'acide gamma-oxo-alpha-(phenylmethyl)-5,6- dihydro-4h-thieno(3,4-c)pyrrole-5-butanoique, leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
FR2733750A1 FR2733750A1 (fr) 1996-11-08
FR2733750B1 true FR2733750B1 (fr) 1997-06-13

Family

ID=9478644

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9505260A Expired - Fee Related FR2733750B1 (fr) 1995-05-03 1995-05-03 Derives de l'acide gamma-oxo-alpha-(phenylmethyl)-5,6- dihydro-4h-thieno(3,4-c)pyrrole-5-butanoique, leur preparation et leur application en therapeutique

Country Status (22)

Country Link
US (1) US5869518A (fr)
EP (1) EP0823912A1 (fr)
JP (1) JPH11504913A (fr)
KR (1) KR19990008276A (fr)
AR (1) AR001838A1 (fr)
AU (1) AU699120B2 (fr)
BG (1) BG102015A (fr)
BR (1) BR9608309A (fr)
CA (1) CA2220015A1 (fr)
CO (1) CO4750652A1 (fr)
CZ (1) CZ346697A3 (fr)
EE (1) EE9700288A (fr)
FR (1) FR2733750B1 (fr)
HU (1) HUP9903886A3 (fr)
IL (1) IL118119A0 (fr)
NO (1) NO975020L (fr)
NZ (1) NZ307230A (fr)
PL (1) PL323177A1 (fr)
SK (1) SK147897A3 (fr)
TR (1) TR199701287T1 (fr)
WO (1) WO1996034870A1 (fr)
ZA (1) ZA963485B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2752422B1 (fr) 1996-08-16 1998-11-06 Lipha Composition pharmaceutique contenant des acides 4-oxo-butanoiques
JP2001514631A (ja) * 1997-03-07 2001-09-11 ノボ ノルディスク アクティーゼルスカブ ４，５，６，７−テトラヒドロ−チエノ［３，２−ｃ］ピリジン誘導体類、それらの製造方法及び使用
US6177443B1 (en) 1997-03-07 2001-01-23 Novo Nordisk A/S 4,5,6,7-tetrahydro-thieno[3, 2-C]pyridine derivatives, their preparation and use
AU2610499A (en) * 1998-03-06 1999-09-20 Novo Nordisk A/S 4,5,6,7-tetrahydro-thieno(3,2-c)pyridine derivatives
FR2777566B1 (fr) * 1998-04-15 2003-02-21 Synthelabo Derives d'azacycloalcanes, leur preparation et leur application en therapeutique
FR2779428B1 (fr) * 1998-06-03 2001-05-18 Synthelabo Derives d'oxo-azacycloalcanes, leurs preparations et leurs applications en therapeutique
WO2000014090A1 (fr) * 1998-09-02 2000-03-16 Novo Nordisk A/S Derives de 4,5,6,7-tetrahydro-thieno[2,3-c]pyridine
US6090797A (en) * 1998-09-02 2000-07-18 Novo Nordisk A/S 4,5,6,7-tetrahydro-thieno(2,3-C)pyridine derivatives
FR2793411B1 (fr) * 1999-05-11 2001-06-29 Synthelabo Utilisation de derives de l'acide succinique pour obtenir un medicament destine au traitement de l'inflammation
DK1088824T3 (da) * 1999-09-30 2004-04-13 Pfizer Prod Inc Bicykliske pyrrolylamider som glycogen phosphorylase inhibitorer
US6797820B2 (en) 1999-12-17 2004-09-28 Vicuron Pharmaceuticals Inc. Succinate compounds, compositions and methods of use and preparation
AR036053A1 (es) 2001-06-15 2004-08-04 Versicor Inc Compuestos de n-formil-hidroxilamina, un proceso para su preparacion y composiciones farmaceuticas
DE60219630T2 (de) * 2001-06-15 2007-12-27 Vicuron Pharmaceuticals, Inc., Fremont Bicyclische pyrrolidinverbindungen
US20090312470A1 (en) * 2008-06-11 2009-12-17 Ferro Corporation Asymmetric Cyclic Diester Compounds
US20100113664A1 (en) * 2008-06-11 2010-05-06 Ferro Corporation Asymmetric Cyclic Diester Compounds
WO2010046108A1 (fr) * 2008-10-24 2010-04-29 Grünenthal GmbH 4,5,6,7-tétrahydrothiénopyridines substituées, comme modulateurs des kcnq2/3 pour le traitement de la douleur, de l'épilepsie et de l'incontinence urinaire
AR083855A1 (es) 2010-11-15 2013-03-27 Abbott Lab Inhibidores de nampt y rock

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3190950A (en) * 1961-03-13 1965-06-22 Acf Ind Inc Pictorial position display
US3706810A (en) * 1970-09-15 1972-12-19 American Cyanamid Co N-morpholinoalkyl-thieno(3,2-b)pyrrole-5-carboxamides
ZA821020B (en) * 1981-02-18 1983-10-26 Thomae Gmbh Dr K Azepine derivatives, process for their preparation and pharmaceutical compositions thereof
FR2537974A1 (fr) * 1982-12-16 1984-06-22 Adir Nouveaux derives de thieno (2,3-b) pyrrole, leur procede de preparation et les compositions pharmaceutiques les renfermant
FR2571723B1 (fr) * 1984-10-12 1988-08-26 Lipha Derives de thieno et furo-(2,3-c) pyrroles, procedes de preparation et medicaments les contenant
FR2652579B1 (fr) * 1989-10-02 1992-01-24 Sanofi Sa Derives d'hydroxy-2 thiophene et furanne condenses avec un cycle azote, sur procede de preparation et leur application en therapeutique.
FR2676446B1 (fr) * 1991-05-17 1993-08-06 Rhone Poulenc Rorer Sa Nouveaux derives du thiopyranopyrrole, leur preparation et les compositions pharmaceutiques qui les contiennent.
EP0599697A1 (fr) * 1992-11-24 1994-06-01 Synthelabo Dérivés de pyrrole, leur préparation et leur application en thérapeutique
FR2719844B1 (fr) * 1994-05-10 1996-06-07 Synthelabo Dérivés de 5,6-dihydro-4h-thiéno[3,4-c]pyrrole, leur préparation et leur application en thérapeutique.

Also Published As

Publication number Publication date
MX9708322A (es) 1998-06-28
WO1996034870A1 (fr) 1996-11-07
NO975020L (no) 1998-01-05
ZA963485B (en) 1996-11-25
NO975020D0 (no) 1997-10-31
SK147897A3 (en) 1998-05-06
CZ346697A3 (cs) 1998-02-18
AR001838A1 (es) 1997-12-10
EE9700288A (et) 1998-04-15
HUP9903886A3 (en) 2000-04-28
TR199701287T1 (xx) 1998-03-21
IL118119A0 (en) 1996-09-12
AU5652096A (en) 1996-11-21
AU699120B2 (en) 1998-11-19
BG102015A (en) 1998-08-31
FR2733750A1 (fr) 1996-11-08
JPH11504913A (ja) 1999-05-11
US5869518A (en) 1999-02-09
KR19990008276A (ko) 1999-01-25
BR9608309A (pt) 1999-01-26
HUP9903886A2 (hu) 2000-03-28
EP0823912A1 (fr) 1998-02-18
NZ307230A (en) 1998-11-25
PL323177A1 (en) 1998-03-16
CA2220015A1 (fr) 1996-11-07
CO4750652A1 (es) 1999-03-31

Similar Documents

Publication Publication Date Title
FR2733750B1 (fr) Derives de l'acide gamma-oxo-alpha-(phenylmethyl)-5,6- dihydro-4h-thieno(3,4-c)pyrrole-5-butanoique, leur preparation et leur application en therapeutique
FR2769915B1 (fr) Derives d'indazole tricycliques, leur preparation et leur application en therapeutique
FR2754262B1 (fr) Derives de 1h-pyrido[3,4-b]indole-4-carboxamide, leur preparation et leur application en therapeutique
FR2681325B1 (fr) Derives de l'aminomethyl-4 piperidine, leur preparation et leur application en therapeutique.
FR2728900B1 (fr) Derives de 3-phenylisoquinolein-1(2h)-one, leur preparation et leur application en therapeutique
FR2766823B1 (fr) Derives de 4-oxo-3,5-dihydro-4h-pyridazino[4,5-b] indole-1-acetamide, leur preparation et leur application en therapeutique
FR2771093B1 (fr) Derives d'imidazole, leur preparation et leur application en therapeutique
FR2761072B1 (fr) Derives de 2,3-dihydrofuro[3,2-b]pyridine, leur preparation et leur application en therapeutique
FR2737494B1 (fr) Derives de benzenesulfonamide, leur preparation et leur application en therapeutique
FR2742153B1 (fr) Utilisation de derives tricycliques du 1,4-dihydro-1,4- dioxo-1h-naphtalene, nouveaux composes obtenus et leur application en therapeutique
FR2761068B1 (fr) Derives de piperazin-4-ylthieno[3,2-c]pyridin-4-yl-2- carboxamide, leur preparation et leur application en therapeutique
FR2634207B1 (fr) Derives de ((piperidinyl-4)methyl) benzazepines, leur preparation et leur application en therapeutique
FR2765582B1 (fr) Derives de 3-alkyl-1,9-dihydro-2h-pyrido[2,3-b]indol-2-one leur preparation et leur application en therapeutique
FR2638747B1 (fr) Derives de phenyloxypropanolamines, leur preparation et leur application en therapeutique
FR2761070B1 (fr) Derives de dihydropyrazino[1,2-a]indole-1-one, leur preparation et leur application en therapeutique
FR2772378B1 (fr) Derives d'imidazole, leur preparation et leur application en therapeutique
FR2742152B1 (fr) Derives de 5-naphtalen-1-yl-1,3-dioxanes, leur preparation et leur application en therapeutique
FR2751970B1 (fr) Derives d'acide 6,7,8,9-tetrahydro-5h-imidazo[1,2-a]azepine- 3-acetique, leur preparation et leur application en therapeutique
FR2753196B1 (fr) Derives d'indazole tricyclique, leur preparation et leur application en therapeutique
FR2741072B1 (fr) Derives d'oxazolidin-2-one, leur preparation et leur application en therapeutique
FR2724382B1 (fr) Derives de 2-aminopyrimidine-4-carboxamide, leur preparation et leur application en therapeutique
FR2756564B1 (fr) Derives d'acide quinoleine-8-carboxylique, leur preparation et leur application en therapeutique
FR2735776B1 (fr) Derives de 2,3-dihydro-1h-indole, leur preparation et leur application en therapeutique
FR2769914B1 (fr) Derives d'indazole tricycliques leur preparation et leur application en therapeutique
FR2606409B1 (fr) Derives d'imidazopyridine, leur preparation et leur application en therapeutique

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse

Effective date: 20060131